Mostrar el registro sencillo del ítem
dc.contributor.author
Padula, Paula Julieta
dc.contributor.author
Colavecchia, Silvia Beatriz
dc.contributor.author
Martinez, Valeria Paula
dc.contributor.author
Gonzalez Della Valle, M. O.
dc.contributor.author
Edelstein, Andres Ivan
dc.contributor.author
Miguel, S. D. L.
dc.contributor.author
Russi, J.
dc.contributor.author
Riquelme, J. Mora
dc.contributor.author
Colucci, N.
dc.contributor.author
Almirón, M.
dc.contributor.author
Rabinovich, Roberto Daniel
dc.date.available
2018-05-10T13:01:59Z
dc.date.issued
2000-08
dc.identifier.citation
Padula, Paula Julieta; Colavecchia, Silvia Beatriz; Martinez, Valeria Paula; Gonzalez Della Valle, M. O.; Edelstein, Andres Ivan; et al.; Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America; American Society for Microbiology; Journal of Clinical Microbiology; 38; 8; 8-2000; 3029-3035
dc.identifier.issn
0095-1137
dc.identifier.uri
http://hdl.handle.net/11336/44719
dc.description.abstract
Since 1995 when the first case of hantavirus pulmonary syndrome (HPS) was reported in Patagonia, there have been more than 400 cases of HPS reported in five countries in South America. The first case of HPS was associated with Andes (AND) virus. In this study, we report on the genetic diversity, geographical distribution, and serological features of hantavirus infection in six countries in South America based on 87 HPS cases from Argentina, Bolivia, Chile, Paraguay, and Uruguay. An early immunoglobulin M (IgM), IgA, and IgG humoral response was observed in almost all HPS cases. The IgM response appears to peak 1 or 2 days after the onset of symptoms. Peak IgG antibody titers occur mostly after the first week. Low IgG titers or the absence of IgG was associated with higher mortality rates. The IgA response peaks around day 15 and then rapidly decreases. The results of phylogenetic analysis based on partial M-fragment G1- and G2-encoding sequences showed that HPS cases from the five countries were infected with viruses related to AND or Laguna Negra (LN) virus. Within AND virus-infected persons, at least five major genetic lineages were found; one lineage was detected in Uruguayan and Argentinean cases from both sides of the Rio de la Plata river. Two Paraguayan patients were infected with a virus different from LN virus. According to the results of phylogenetic analyses, this virus probably belongs to a distinct lineage related more closely to the AND virus than to the LN virus, suggesting that there is probably an Oligoryzomys-borne viral variant circulating in Paraguay. These studies may contribute to a better understanding of hantavirus human infection in South America.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
American Society for Microbiology
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Hantavirus
dc.subject
Genetic Diversity
dc.subject
South America
dc.subject
Serology
dc.subject.classification
Enfermedades Infecciosas
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2018-03-16T15:17:06Z
dc.identifier.eissn
1098-660X
dc.journal.volume
38
dc.journal.number
8
dc.journal.pagination
3029-3035
dc.journal.pais
Estados Unidos
dc.journal.ciudad
Washington
dc.description.fil
Fil: Padula, Paula Julieta. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.description.fil
Fil: Colavecchia, Silvia Beatriz. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.description.fil
Fil: Martinez, Valeria Paula. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.description.fil
Fil: Gonzalez Della Valle, M. O.. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.description.fil
Fil: Edelstein, Andres Ivan. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.description.fil
Fil: Miguel, S. D. L.. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.description.fil
Fil: Russi, J.. Ministerio de Salud Pública; Uruguay
dc.description.fil
Fil: Riquelme, J. Mora. Ministerio de Salud Pública; Chile
dc.description.fil
Fil: Colucci, N.. Ministerio de Salud Pública y Bienestar Social; Paraguay
dc.description.fil
Fil: Almirón, M.. Universidad Nacional de Asunción; Paraguay
dc.description.fil
Fil: Rabinovich, Roberto Daniel. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina
dc.journal.title
Journal of Clinical Microbiology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://jcm.asm.org/content/38/8/3029.full.pdf+html
Archivos asociados